Welcome to today’s episode of the PeDRA Pearls Podcast! In this installment, Dr. Colleen Cotton is joined by Dr. Mana Nasseri to discuss their research project titled "Impact of Bariatric Surgery on Pediatric Hidradenitis Suppurativa." Tune in as they share what inspired this important work, key insights from their findings, and the questions that still remain. Whether you're a clinician, researcher, or simply curious about the intersection of dermatology and pediatric obesity, this episode is full of valuable perspectives you won’t want to miss.

Updates:

• Dash for Discovery
• PeDRA Annual Conference
• PeDRA Awards Program
• PeDRA Mentorship Program - Now Open!

In episode seventeen, PeDRA Pub Club host Hannah Chang and guest panelists, Bella Plumptre, MD, and Cheryl Bayart, MD, discuss a recent PeDRA publication, Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases published in Pediatric Dermatology in 2024.

PeDRA Awards Program

PeDRA Annual Conference

Following the June 23 OX40 webinar, Dr. Eichenfield, Dr. Simpson, and Dr. Wan continue the conversation with a look ahead at the future of OX40 therapies and their potential to change the course of disease. They also unpack the complex concept of remission in atopic dermatitis—what it means, how it's defined, and whether it's truly achievable.

To watch the OX40 webinar, please click here.

Disclosures:

Lawrence Eichenfield, MD has served as a consultant, speaker, advisory board member, or investigator for AbbVie, Acrotech, Almirall, Amgen, Apogee, Arcutis, Attovia, Bristol Myers Squibb, Castle Biosciences, CorEvitas, Dermavant, Eli Lilly, Forte, Galderma, Incyte Corporation, Janssen, Johnson & Johnson, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi Genzyme, Target RWE, T-Rex, and UCB.

Eric Simpson, MD reports personal fees from AbbVie, Aclaris Therapeutics, Amgen, Arcutis, Astria Therapeutics, Attovia Therapeutics, Inc., Bambusa Therapeutics Inc., Castle, CorEvitas, Dermira, Eli Lilly, Evomunne, FIDE, Impetus Healthcare, Incyte, Innovaderm Reche/ Indero, Inmagene Biopharmaceuticals, Janssen, LectureLinx (LLX), Leo, NUMAB Therapeutics AG, Pfizer, Recludix Pharma, Regeneron, Roche Products Ltd, Sanofi-Genzyme, SITRYX Therapeutics

Eric Simpson, MD reports grants (or serves as Principal investigator role) for AbbVie, Acrotech, Amgen, Arcutis, ASLAN, Castle, Dermavant, CorEvitas, Dermira, Eli Lilly, Incyte, Pfizer, Regeneron, Sanofi-Genzyme, Target, VeriSkin

Joy Wan, MD Sun Pharmaceuticals - consulting (DMC), Astria Therapeutics - consulting (ad board), Galderma - fellowship funding (paid to Johns Hopkins)